Remove Doctors Remove FDA Remove Leads Remove Side effects
article thumbnail

The debate on DTC marketing is going to heat up again

World of DTC Marketing

DTC ads do NOT lead to unnecessary Rxs. The FDA needs to study what people do when they see a DTC ad. Today, people don’t see a DTC TV ad and run to their doctor to ask for an Rx. ” Patients want to understand how the drug works and the potential side effects before starting therapy.

Marketing 285
article thumbnail

A scientific approach to irrational consumer choices

World of DTC Marketing

GOOD MORNING: The FDA is taking a scientific approach to evaluating direct-to-consumer (DTC) drug advertising, focusing on measuring consumer perceptions of the information presented in ads. ” So, are we supposed to believe that better images in DTC ads lead to patients asking for an Rx? ” Uh…no.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

A realistic view of healthcare in 2022

World of DTC Marketing

1ne: The value proposition of prescription drugs still outweighs potential side effects – Wegovy’s demand quickly exceeded supply after the FDA approved once-weekly semaglutide injections. Here are things I believe are more realistic. I expect more companies to integrate more health monitors into wearable devices.

article thumbnail

Jazz Pharma uses flying pig for huge grey area DTC

World of DTC Marketing

This has abuse potential written all over it and could lead to more dangerous health problems. I can see patients asking their doctor for this medication to combat fatigue that we all experience at some time. I can see patients asking their doctor for this medication to combat fatigue that we all experience at some time.

Pharma 181
article thumbnail

Why DTC isn’t, and is, marketing

World of DTC Marketing

CPG marketers are trying to maintain market share amid price increases and smaller product sizes, leading to a more significant jump in consumerism. DTC pharma marketers must acknowledge that people’s days of seeing a TV ad and running to their doctor to ask for the product are all but gone.

Marketing 252
article thumbnail

Biogen’s Alzheimer’s drug: What’s the price tag on hope?

World of DTC Marketing

SUMMARY: The FDA is coming under intense pressure to approve Biogen’s Alzheimer’s drug, but Aaron S. Since that time, Biogen’s MS drugs have faced intense competition as MS patients continue to vent on social media that the Biogen drug has nasty side effects. Too many doctors, the data was still questionable.

article thumbnail

FDA makes moves to advance ALS research ahead of upcoming Amylyx AdCom

Pharmaceutical Technology

In the lead-up to a critical meeting that will influence the approval of a new drug for amyotrophic lateral sclerosis (ALS), the US Food and Drug Administration (FDA) has detailed its plans to advance rare neurodegenerative disease research. The FDA’s action plan. The first AdCom was critical of the study’s robustness.

FDA 98